Steven Yatomi-Clarke

Mr Yatomi-Clarke, at Prescient, manages a team in Australia and the US and has been in strategy development; licensing; initiating and managing clinical trials; identifying research directions and pre-clinical research design; fundraising and business development. He has over 17 years of experience in investment banking specialising in healthcare and biotechnology, where he involved in primary and secondary offerings, corporate advisory and mergers and acquisitions assignments for pharmaceutical and medical device companies. He has also been a collaborator on clinical trials conducted in Australia and the US in the field of cancer immunotherapy.